Feb 1, 1972

Nature of the calcium dependent potassium leak induced by (+)-propranolol, and its possible relevance to the drug's antiarrhythmic effect

British Journal of Pharmacology
I M Glynn, A E Warner

Abstract

1. Manninen (1970) recently reported that in the presence of calcium ions, (+)-propranolol causes a massive loss of potassium ions from human red cells, together with a marked inward ;counter-transport' of potassium ions from the medium.2. This paper shows, theoretically, that counter-transport of the kind he observed may be accounted for by the setting up of a diffusion potential across the cell membrane and does not imply that, under the influence of propranolol, potassium ions cross the membrane by some process other than free diffusion.3. The physiological and pharmacological significance of this interpretation of Manninen's findings is briefly discussed.

Mentioned in this Paper

Chloride Ion Level
Calcium [EPC]
Membrane
Calcium
Resting Potentials
Potassium
Calcium ion
Anti-Arrhythmia Agents
Antiarrhythmic [EPC]
Cardiac Depressants

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.